- Conditions
- Ebola Sudan Virus Disease
- Interventions
- rVSV∆G-SEBOV-GP Vaccine or Placebo
- Drug
- Lead sponsor
- International AIDS Vaccine Initiative
- Network
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 2
- States / cities
- Austin, Texas • San Antonio, Texas
Source: ClinicalTrials.gov public record
Updated Nov 5, 2024 · Synced May 21, 2026, 10:14 PM EDT